Company intelligence / Profile preview

Genencor

Palo Alto, California, United States

Ownership: Private
Employees: ~758
Development stage: Other

Overview

Genencor pioneered industrial enzyme production and protein bioproducts; its biopharmaceutical/drug development programs were discontinued or not advanced beyond early clinical and preclinical phases.

Therapeutic areas: Infectious DiseasesOncologyNeurology
Modalities: ProteinRecombinant proteinDNA vaccine
Industry: Non-Drug Biotech

Partnerships

DuPont (DuPont Danisco Cellulosic Ethanol LLC joint venture)Goodyear (BioIsoprene partnership)

Beyond the preview

Go deeper on Genencor.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Genencor.

Explore the full profile